drug therapy
-
HMG-CoA reductase inhibitors
Donald G. Vidt, MD, Alan W. Bakst, PharmD, RPh, Michael D. Cressman, DO, Byron J. Hoogwerf, MD, Douglas S. Moodie, MD, Jeffrey W. Olin, DO and Cheryl E. Weinstein, MD- Cleveland Clinic Journal of Medicine January 1988, 55 (1) 93-100;
-
Benign essential blepharospasm treated with botulinum toxin
A. Jan Berlin, M.D, Joyce H. Cassen, M.D, Garland DeNelsky, Ph.D, Maurice R. Hanson, M.D and Patrick J. Sweeney, M.D- Cleveland Clinic Journal of Medicine September 1987, 54 (5) 421-426;
-
A case of generalized granuloma annulare responding to hydroxychloroquine
Marie C. Carlin, M.D and John Louis Ratz, M.D., F.A.C.P- Cleveland Clinic Journal of Medicine May 1987, 54 (3) 229-232;
-
Mexiletine therapy in patients with chronic drug-resistant malignant ventricular arrhythmias
Dale L. Haggman, D.O, James D. Maloney, M.D, Victor A. Morant, M.D, Lon W. Castle, M.D, Marilyn King-Rankine, M.D and Marlene Goormastic, M.P.H- Cleveland Clinic Journal of Medicine June 1986, 53 (2) 171-179;
-
Hepatotoxicity of prolonged methotrexate therapy for rheumatoid arthritis
Allen H. Mackenzie, M.D- Cleveland Clinic Journal of Medicine June 1985, 52 (2) 129-135;
-
Streptobacillary fever
David R. Mandel, M.D- Cleveland Clinic Journal of Medicine June 1985, 52 (2) 203-205;
-
Pharmacologic management of migraine—1985
Donald G. Vidt, M.D, Alan W. Bakst, Pharm.D., R.Ph and Robert S. Kunkel, M.D- Cleveland Clinic Journal of Medicine March 1985, 52 (1) 95-101;
-
Plasma insulin and glucose levels in diabetic patients undergoing continuous ambulatory peritoneal dialysis using insulin only in the dialysate
Elizabeth T. Dolgos, M.D, Donald G. Vidt, M.D, O. Peter Schumacher, M.D., Ph.D and Manjula K. Gupta, Ph.D- Cleveland Clinic Journal of Medicine December 1984, 51 (4) 611-614;
-
A compendium for the treatment of hypertensive emergencies
Donald G. Vidt, M.D, Alan W. Bakst, Pharm.D., R.Ph and Ray W. Gifford Jr., M.D- Cleveland Clinic Journal of Medicine June 1984, 51 (2) 421-430;